CLOVIGAN valganciclovir (as hydrochloride) 450mg film coated tablet bottle

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

valganciclovir hydrochloride, Quantity: 496.3 mg (Equivalent: valganciclovir, Qty 450 mg)

Mevcut itibaren:

Arrotex Pharmaceuticals Pty Ltd

Farmasötik formu:

Tablet, film coated

Kompozisyon:

Excipient Ingredients: stearic acid; silicon dioxide; crospovidone; croscarmellose sodium; povidone; microcrystalline cellulose; titanium dioxide; hypromellose; polysorbate 80; iron oxide red; macrogol 400

Uygulama yolu:

Oral

Paketteki üniteler:

60

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

Valganciclovir is indicated for the treatment of cytomegalovirus (CMV) retinitis in adult patients with acquired immunodeficiency syndrome (AIDS).,Valganciclovir is indicated for the prophylaxis of CMV disease in adult and paediatric solid organ transplantation (SOT) patients who are at risk.

Ürün özeti:

Visual Identification: Pink coloured, oval shaped, biconvex, film-coated tablets with "VLG" debossed on one side and "450" on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Yetkilendirme durumu:

Registered

Yetkilendirme tarihi:

2019-05-16